EP-1325: Outcomes of stereotactic radiotherapy for brain metastases in different breast cancer subtypes
نویسندگان
چکیده
منابع مشابه
[Stereotactic radiosurgery and radiotherapy for brain metastases].
Brain metastases management is still controversial even though many trials are trying to define the respective roles of neurosurgery, whole-brain radiotherapy, single-dose stereotactic radiotherapy and fractionated stereotactic radiotherapy. In this article, we review data from trials that examine the role of radiosurgery and fractionated stereotactic radiotherapy in the management of brain met...
متن کاملBrain metastases and breast cancer subtypes.
fer significantly. Although this might be a good opportunity to review the association of TNBC and HER-positive tumors with brain metastases, it is difficult to interpret the data without having the denominators for each breast cancer subtype and see the true incidence of brain metastases in each group. With the known overall poor prognostic outcome associated with TNBC, and the inference from ...
متن کاملStereotactic radiotherapy in epithelial ovarian cancer brain metastases patients
BACKGROUND In this report we present the results of the retrospective (survival and classification) analyses of possible prognostic factors prolonging survival in epithelial ovarian cancer brain metastases patients after stereotactic radiotherapy. We focus on a wide range of available predictors to establish survival in patients with a good health status and no more than three lesions. METHOD...
متن کاملHypofractionated stereotactic radiotherapy for the treatment of brain metastases.
BACKGROUND This retrospective review evaluated the efficacy and toxicity profiles of various dose fractionations using hypofractionated stereotactic radiotherapy (HSRT) in the treatment of brain metastases. METHODS Between 2004 and 2007, 36 patients with 66 brain metastases were treated with HSRT. Nine of these subjects were excluded because of the absence of post-treatment magnetic resonance...
متن کاملStereotactic Radiotherapy for Liver Metastases
Liver metastases are common in oncologic patients, causing substantial morbidity and mortality. Systemic therapy is now standard palliative treatment for most patients with liver metastases, often providing transient responses and increased overall survival. In selected oligometastatic patients, local treatment can lead to long disease-free intervals and even permanent disease control. Although...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Radiotherapy and Oncology
سال: 2018
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(18)31635-9